Rectal toxicity profile after transperineal interstitial permanent prostate brachytherapy: Use of a comprehensive toxicity scoring system and identification of rectal dosimetric toxicity predictors

International Journal of Radiation Oncology Biology Physics

Volumn 64, Issue 3, 2006, Pages 817-824

  Shah, Jinesh N ^a   Ennis, Ronald D ^a,b  

^a Columbia University ^*  (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

Brachytherapy; Dosimetry; Prostate cancer; Rectal toxicity

Indexed keywords

DOSIMETERS; HORMONES; IMPLANTS (SURGICAL); PATIENT TREATMENT; TUMORS;

BRACHYTHERAPY; PROSTATE CANCER; RECTAL TOXICITY;

TOXICITY;

ANTIANDROGEN; GONADORELIN AGONIST; IODINE 125; PALLADIUM 103;

ADULT; AGED; ARTICLE; BLEEDING; BRACHYTHERAPY; CANCER STAGING; CONTROLLED STUDY; DIARRHEA; DOSIMETRY; FOLLOW UP; GASTROINTESTINAL TOXICITY; HORMONAL THERAPY; HUMAN; INCONTINENCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MUSCLE SPASM; PAIN; PRIORITY JOURNAL; PROCTITIS; PROSTATE CANCER; RECTUM DISEASE; SCORING SYSTEM; TOXICITY TESTING; URINARY URGENCY;

AGED; BRACHYTHERAPY; DIARRHEA; GASTROINTESTINAL DISEASES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIATION DOSAGE; RADIATION INJURIES; RECTUM;

EID: 31844449376     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.08.042     Document Type: Article

References (40)

1. A.V. D'Amico, R. Whittington, S.B. Malkowicz Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1998 969 974
2. M.J. Zelefsky, K.E. Wallner, C.C. Ling Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent Iodine-125 implantation for early-stage prostatic cancer J Clin Oncol 17 1999 517 522
3. D.G. Brachman, T. Thomas, J. Hilbe Failure-free survival following brachytherapy alone or external beam irradiation alone for T1-2 prostate tumors in 2222 patients Results from a single practice Int J Radiat Oncol Biol Phys 48 2000 111 117
4. P.A. Kupelian, L. Potters, D. Khuntia Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy <72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer Int J Radiat Oncol Biol Phys 58 2004 25 33
5. K.W. Kaye, D.J. Olson, J.T. Payne Detailed preliminary analysis of Iodine-125 implantation for localized prostate cancer using percutaneous approach J Urol 153 1995 1020 1025
6. S. Nag, D.D. Scaperoth, R. Badalament Transperineal palladium 103 prostate brachytherapy Analysis of morbidity and seed migration Urology 45 1995 87 92
7. K. Wallner, J. Roy, L. Harrison Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy Int J Radiat Oncol Biol Phys 32 1995 465 471
8. 125I prostate implantation Int J Radiat Oncol Biol Phys 37 1997 559 563
9. K. Hu, K. Wallner Clinical course of rectal bleeding following I-125 prostate brachytherapy Int J Radiat Oncol Biol Phys 41 1998 263 265
10. G.S. Merrick, W.M. Butler, A.T. Dorsey Rectal dosimetric analysis following prostate brachytherapy Int J Radiat Oncol Biol Phys 43 1999 1021 1027
11. M.J. Zelefsky, K.E. Wallner, C.C. Ling Comparison of the 5-yr outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent Iodine-125 implantation for early-stage prostatic cancer J Clin Oncol 17 1999 517 522
12. D.Y. Gelblum, L. Potters Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer Int J Radiat Oncol Biol Phys 48 2000 119 124
13. 125I prostate brachytherapy using a rectal dose-volume histogram analysis Int J Radiat Oncol Biol Phys 50 2001 335 341
14. 125I prostate brachytherapy Int J Radiat Oncol Biol Phys 55 2003 342 353
15. M.J. Zelefsky, Y. Yamada, C. Marion Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapy Int J Radiat Oncol Biol Phys 55 2003 956 963
16. C.A. Lawton, M. Won, M.V. Pilepich Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate Analysis of RTOG studies 7506 and 7706 Int J Radiat Oncol Biol Phys 21 1991 935 939
17. J.D. Cox, J. Stetz, T.F. Pajak Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1995 1341 1346
18. National Cancer Institute Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events version 3.0. NCI CTEP Website. http://ctep.info.nih.gov.
19. A. Trotti, R. Byhardt, J. Stetz Common toxicity criteria: Version 2.0. An improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy Int J Radiat Oncol Biol Phys 47 2000 13 47
20. A. Trotti, A.D. Colevas, A. Setser CTCAE v3.0 Development of a comprehensive grading system for the adverse effects of cancer treatment Semin Radiat Oncol 13 2003 176 181
21. P. Wust, D.W. von Borczyskowski, T. Henkel Clinical and physical determinants for toxicity of 125-I seed prostate brachytherapy Radiother Oncol 73 2004 39 48
22. R.M. Gewanter, C.-S. Wuu, J.L. Laguna Intraoperative preplanning for transperineal ultrasound-guided permanent prostate brachytherapy Int J Radiat Oncol Biol Phys 48 2000 377 380
23. R. Nath, L.L. Anderson, G. Luxton Dosimetry of interstitial brachytherapy sources Recommendations of the AAPM Radiation Therapy Committee Task Force Group No. 43 Med Phys 22 1995 209 234
24. J.F. Williamson, B.M. Coursey, L.A. DeWerd Recommendations of the American Association of Physicists in Medicine on 103Pd interstitial source calibration and dosimetry Implications for dose specification and prescription Med Phys 27 2000 634 642
25. 103Palladium brachytherapy Int J Radiat Oncol Biol Phys 47 2000 273 275
26. P.C. Lee, B.J. Moran 125 Gy or 135 Gy? Comments on the American Brachytherapy Society article by Beyer et al. IJROBP 47 2000 273 275 [Letter]. Int J Radiat Oncol Biol Phys 2001;49:897-898.
27. J.M. Michalski, J.F. Williamson In regard to Beyer, Nath, and Butler, et al. IJROBP 47 2000 273 275 [Letter]. Int J Radiat Oncol Biol Phys 2001;49:900.
28. N. Yue, A.P. Dicker, B.W. Corn A dynamic model for the estimation of optimum timing of computed tomography scan for dose evaluation of I-125 or Pd-103 seed implant of prostate Int J Radiat Oncol Biol Phys 43 1999 447 454
29. Radiation Therapy Oncology Group. RTOG 0321. Phase II trial of combined high dose rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate. RTOG Website. http://www.rtog.org.
30. G.S. Merrick, W.M. Butler, K.E. Wallner Late rectal function after prostate brachytherapy Int J Radiat Oncol Biol Phys 57 2003 42 48
31. G.S. Merrick, W.M. Butler, K.E. Wallner Rectal function following brachytherapy with or without supplemental external beam radiation Results of two prospective randomized trials Brachytherapy 2 2003 147 157
32. M.J. Zelefsky, T. Hollister, A. Raben Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer Int J Radiat Oncol Biol Phys 47 2000 1261 1266
33. G.S. Merrick, W.M. Butler, A.T. Dorsey Rectal function following prostate brachytherapy Int J Radiat Oncol Biol Phys 48 2000 667 674
34. 125I prostate brachytherapy implants Int J Radiat Oncol Biol Phys 53 2002 775 785
35. G. Sanguineti, S. Agostinelli, F. Foppiano Adjuvant androgen deprivation impacts late rectal toxicity after conformal radiotherapy of prostate carcinoma Br J Cancer 86 2002 1843 1847
36. V. Vavassori, C. Cozzarini, C. Bianchi Androgen deprivation and late rectal bleeding after radiotherapy for prostate carcinoma Int J Radiat Oncol Biol Phys 54 Suppl 2002 109
37. R. Valicenti, K. Winter, J.D. Cox The effect on toxicity of induction hormonal therapy in prostate cancer patients receiving dose escalated 3D conformal radiation therapy on RTOG 94-06 Int J Radiat Oncol Biol Phys 54 Suppl 2002 133
38. M.C. Liu, T. Pickles, A. Agranovich Impact of neoadjuvant androgen ablation and other factors on late toxicity following external beam prostate radiation Int J Radiat Oncol Biol Phys 54 Suppl 2002 263
39. G.S. Merrick, W.M. Butler, K.E. Wallner Influence of hormonal therapy on late rectal function after permanent prostate brachytherapy with or without supplemental external beam radiotherapy Int J Radiat Oncol Biol Phys 58 2004 68 74
40. F.M. Waterman, A.P. Dicker Effect of post-implant edema on the rectal dose in prostate brachytherapy Int J Radiat Oncol Biol Phys 45 1999 571 576